Author

Alexander Buchner

Professor, Department of Urology, University of Munich, Germany - Cited by 5,528 - Urology - Oncology - Prognostic Factors - Artificial Neural Networks - Gene Expression Analysis

Biography

Dr.  Alexander Buchner is currently working in 1Department of Urology, Ludwig-Maximilians-University, Munich, Germany. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work. 
Title
Cited by
Year
Digital real-world data suggest patient preference for tadalafil over sildenafil in patients with erectile dysfunction
M von Büren, S Rodler, I Wiesenhütter, F Schröder, A Buchner, C Stief, ...European Urology Focus 8 (3), 794-802, 2022202
12
2022
Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients?
S Rodler, L Eismann, B Schlenker, J Casuscelli, I Brinkmann, ...Cancers 14 (18), 4411, 2022202
6
2022
The role of Shikonin in improving 5-aminolevulinic acid-based photodynamic therapy and chemotherapy on glioblastoma stem cells
The role of Shikonin in improving -aminolevulinic acid-based photodynamic therapy and chemotherapy on glioblastoma stem cellsM Werner, C Lyu, B Stadlbauer, I Schrader, A Buchner, H Stepp, R Sroka, ...Photodiagnosis and Photodynamic Therapy 39, 102987, 2022202
5
2022
Identification of EZH2 as cancer stem cell marker in clear cell renal cell carcinoma and the anti-tumor effect of epigallocatechin-3-Gallate (EGCG)
C Lyu, L Wang, B Stadlbauer, E Noessner, A Buchner, H PohlaCancers 1 (17), 200, 2022202
4
2022
Long-term health-related quality of life (HRQOL) after radical cystectomy and urinary diversion-a propensity score-matched analysis
Y Volz, L Eismann, P Pfitzinger, T Westhofen, B Ebner, JF Jokisch, ...Clinical Genitourinary Cancer 20 (), e283-e290, 2022202
4
2022
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer
S Garczyk, S Degener, F Bischoff, T Schnitzler, A Salz, R Golz, A Buchner, ...Virchows Archiv 481 (1), 8-92, 2022202
3
2022
Definition and impact on oncologic outcomes of persistently elevated prostate-specific antigen after salvage lymph node dissection for node-only recurrent prostate cancer after …
CA Bravi, M Droghetti, N Fossati, G Gandaglia, N Suardi, E Mazzone, ...European Urology Oncology 5 (), 285-295, 2022202
3
2022
Baseline Health-related Quality of Life Predicts Bladder Cancer–specific Survival Following Radical Cystectomy
T Westhofen, L Eismann, A Buchner, B Schlenker, C Giessen-Jung, ...European Urology Focus 8 (6), 1659-1665, 0
2
2022
Identification of the Tumor Infiltrating Lymphocytes (TILs) Landscape in Pure Squamous Cell Carcinoma of the Bladder
L Eismann, S Rodler, A Buchner, GB Schulz, Y Volz, R Bischoff, B Ebner, ...Cancers 14 (16), 3999, 0
2
2022
Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer
S Rodler, O Solyanik, M Ingenerf, M Fabritius, GB Schulz, F Jokisch, ...World Journal of Urology 40 (7), 1707-1714, 0
2
2022
Interstitial Photodynamic Therapy of Glioblastomas: A Long-Term Follow-up Analysis of Survival and Volumetric MRI Data
M Foglar, M Aumiller, K Bochmann, A Buchner, M El Fahim, S Quach, ...Cancers 5 (9), 2603, 2023202
1
2023
Age and ECOG performance status as predictors of survival of patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy
L Eismann, L Bohn, A Buchner, J Casuscelli, Y Volz, P Weinhold, ...Urologia Internationalis 07 (), 72-79, 2023202
1
2023
A Pan-Cancer Landscape of ABCG2 across Human Cancers: Friend or Foe?
C Lyu, L Wang, B Stadlbauer, A Buchner, H PohlaInternational Journal of Molecular Sciences 23 (24), 5955, 2022202
1
2022
The burden of fear of cancer recurrence in genitourinary cancers: a prospective study (NCT04535921)
The burden of fear of cancer recurrence in genitourinary cancers: a prospective study (NCT0453592)Y Volz, J Troost, L Eismann, F Jokisch, GB Schulz, B Schlenker, ...Oncology Research and Treatment 45 (2), 744-75, 2022202
1
2022

Referred From: https://scholar.google.com/citations?hl=en&user=azHX8YAAAAAJ

Cited by
Citations 5528
h-index 42
i10-index 125
Recommended Journals
Open Access Journals